Ergoloid Mesylates
NDC Package 0172-2959-80
Package Information
Ergoloid Mesylates is a medication used to treat mild problems with mood, memory, concentration, or behavior in the elderly. Marketed by Ivax Pharmaceuticals, Inc., this product is identified by NDC 0172-2959 and is authorized under FDA application ANDA087185.
Identification & Billing
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 0172 - Ivax Pharmaceuticals, Inc.
- 0172-2959 - Ergoloid Mesylates
- 0172-2959-80 - 1000 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE
- 0172-2959 - Ergoloid Mesylates
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (0172-2959). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 0172-2959-80 identifies a specific commercial package of 1000 tablet, orally disintegrating in 1 bottle of Ergoloid Mesylates, labeled by Ivax Pharmaceuticals, Inc.. This is formulated for use and contains as the active substance.
Is this product currently listed with the FDA?
This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Ivax Pharmaceuticals, Inc. on November 20, 1980. The current certification is valid through September 30, 2008.
What are the primary indications for this medication?
This medication is used to treat mild problems with mood, memory, concentration, or behavior in the elderly. It is believed to increase blood flow to the brain. It is a combination of 3 ergot alkaloids.
How is this Ivax Pharmaceuticals, Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 00172295980. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Labeler segment to maintain the 5-4-2 structure.